An advanced and detailed in vitro validation procedure for the radiolabeling of carrier-free terbutaline sulphate dry powder

Journal of Aerosol Medicine: Deposition, Clearance, and Effects in the Lung

Volumn 14, Issue 2, 2001, Pages 227-236

  Walker, P S ^a,c   Petterson, G L ^b   Bondesson, E ^b   Conway, J H ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^b ASTRAZENECA R AND D   (Sweden)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Dry powder; Pertechnetate; Radiolabeling; Terbutaline; Validation

Indexed keywords

DRUG CARRIER; TECHNETIUM 99M; TERBUTALINE; TERBUTALINE SULFATE;

AEROSOL; ARTICLE; CLINICAL TRIAL; DRUG DELIVERY SYSTEM; DRY POWDER; DYNAMICS; HUMAN; IN VITRO STUDY; ISOTOPE LABELING; PARTICLE SIZE; VALIDATION PROCESS;

EID: 0034880080     PISSN: 08942684     EISSN: None     Source Type: Journal    
DOI: 10.1089/08942680152484153     Document Type: Article

References (5)

1. Total and regional lung deposition of terbutaline sulphate inhaled via a pressurised MDI or via Turbuhaler
2. Deposition and clinical efficacy of terbutaline sulphate from Turbuhaler, a new multidose powder inhaler
3. Preparations for inhalation
4. Assessing lung deposition of inhaled medications
5. Calibration at different flow rates of a multistage liquid impinger